JGJeewani Anupama Ginige

Jeewani Anupama Ginige

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeewani Anupama Ginige has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gold-standard-guided direct preference optimisation for ICD-10-AM and ACHI code assignment from discharge summaries

    by Rajvir Kaur, Jeewani Anupama Ginige, Oliver Obst

    Clinical codes assigned from discharge summaries support clinical research, reimbursement, health resource allocation, and service planning. In Australia,

  • Open Access

    Visualization of Patient Pathways in Clinical Coding: A Systematic Literature Review (Preprint)

    by Iqra Imtiaz, Rajvir Kaur, Jeewani Anupama Gingie

    BACKGROUND Patient-pathway visualisation increasingly supports clinical decision-making, yet it depends fundamentally on the clinical coding systems, principally the International Classification of Diseases (ICD) and the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) that structure the underlying data. Despite widespread adoption, no prior systematic review has examined how the choice of coding system influences the effectiveness and clinical utility of pathway visualisations OBJECTIVE To systematically synthesise how standardised clinical coding systems are combined with visualisation techniques to represent patient pathways; to determine which coding–visualisation combinations have been clinically validated; and to identify the principal interoperability and evidence gaps bearing on implementation. METHODS Following the PRISMA 2020 statement, we searched three bibliographic databases (PubMed, Science Direct, ACM Digital Library), with Google Scholar as a supplementary source, for studies published January 2014 to December 2025. Eligible studies combined a standardised coding system with patient-pathway representation; visualisation was the analytic focus. Of 43,539 records screened, 40 studies met the inclusion criteria and passed a 10-item quality checklist (minimum 7/10). We extracted coding system(s), visualisation method(s), analytic approach, and evaluation strategy, and cross-tabulated coding system against visualisation type and validation status. RESULTS ICD-based coding dominated, appearing in 36 of 40 studies (90%); timeline, flow (including Sankey), and node-link visualisations were most common, typically for single-disease pathways. SNOMED CT appeared in only 4 studies (10%), in every case alongside ICD rather than independently; no study clinically compared ICD with SNOMED CT. Multiple coding systems were combined in 11 studies, but for data coverage rather than unified representation, and none was clinically validated. Notably, only 35 of 40 studies presented a substantive visualisation where 5 represented coded pathways with no visual layer, itself evidence of the visualisation gap. Formal user-centered or clinician evaluation was rare (≈3 of 40, ≈8%), while 9 studies reported no evaluation metrics at all. We found no randomised comparisons, no real-time deployments, and no study quantifying the ICD-9-to-ICD-10 transition’s effect on visualisation. CONCLUSIONS The evidence base is dominated by ICD-coded, single-disease pathway visualisations and offers only limited, largely invalidated support for SNOMED CT or multi-coding approaches. The field’s central unmet need is not more visualisation techniques but rigorous clinical validation and a solution to cross-terminology integration. Priority directions include comparative effectiveness studies of ICD versus SNOMED CT, standardised user-centered evaluation, and multi-site validation; developers should prioritise validated ICD-10 approaches with local pilot testing. CLINICALTRIAL This review was not registered

  • Open Access

    An Australian cross-sectional study exploring the potential role of generative AI in high school computer programming education

    by Jeewani Anupama Ginige, Kritika Rana, Rhys Tague, Benjamin Lum, Hayden Foxwell, Michael Ienna

  • Open Access

    OMOP ETL Framework for Semi-Structured Health Data

    by Jacob Desmond, Ryan Wartmann, Chng Wei Lau, Steven Thomas, Paul M. Middleton, Jeewani Anupama Ginige

    Healthcare data are generated in many different formats, which makes it difficult to integrate and reuse across institutions and studies. Standardisation is required to enable consistent large-scale analysis. The OMOP-CDM, developed by the OHDSI community, provides one widely adopted standard. Our framework achieves schema-agnostic transformation by extending upon existing literature in using human-readable YAML specification to support both relational (Microsoft SQL Server (MSSQL)) and document-based (MongoDB) data sources. It also incorporates critical production readiness features: provenance-aware mapping and support for incremental updates. We validated the pipeline using 2.7 million patient records and 27 million encounters across six hospitals spanning two decades of records. The resulting OMOP-CDM dataset demonstrated an acceptable level of data quality with a 97% overall passing rate based on the OHDSI Data Quality Dashboard check. Our work provides a reusable blueprint for large-scale data harmonisation, directly supporting real-world medical data research.


  • Using Pseudo-Synonyms to Generate Embeddings for Clinical Terms

    by Santosh Purja Pun, Oliver Obst, Jim Basilakis, Jeewani Anupama Ginige


  • Managing Data Uncertainty in Automatic Mapping of Clinical Classification Systems

    by Santosh Purja Pun, Oliver Obst, Jim Basilakis, Jeewani Anupama Ginige

  • Top Cited Papers

    An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial

    by Henry Brodaty, Tiffany Chau, Megan Heffernan, Jeewani A. Ginige, Gavin Andrews, Michael Millard, Perminder S. Sachdev, Kaarin J. Anstey, Nicola T. Lautenschlager, John J. McNeil, et al.

    Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55–77 years with modifiable dementia risk factors. Eligible participants (n = 6,104, 64% female) were randomized 1:1 to a personalized schedule of online coaching in two to four modules (targeting physical activity, nutrition, cognitive activity and depression or anxiety) or a control group that received module-eligible information only. At 3 years, the mean change in a global cognitive composite, the primary outcome, was met. The mean changes in z scores were 0.28 (95% confidence interval (CI): 0.25–0.32) for intervention, 0.10 (95% CI: 0.07–0.13) for control and 0.18 (95% CI: 0.13–0.23, P < 0.001) for the between-group difference. Trial-related adverse events occurred in 19 (0.60%) intervention and 1 (0.03%) control participant. Randomization of this internet-delivered lifestyle intervention tailored to individual dementia risk factors resulted in significantly better cognition in older adults over 3 years. This intervention is scalable with the potential for population-level rollout that may delay cognitive decline in the general community. Australian New Zealand ClinicalTrials.gov registration: ACTRN12618000851268.


  • Open Access

    Smartphone-based eye tracking system using edge intelligence and model optimisation

    by Nishan Gunawardena, Gough Yumu Lui, Jeewani Anupama Ginige, Bahman Javadi


  • Open Access

    Development of an innovative computerized assessment of instrumental activities of daily living

    by Simone Reppermund, Katya T. Numbers, Pinghsiu Lin, Kim Delbaere, Jacqueline Wesson, Lindy Clemson, Jeewani Anupama Ginige, Julian N Trollor, Brian Draper, Henry Brodaty

    Background: Functional impairment is a diagnostic criterion for dementia and distinguishes mild cognitive impairment (MCI) from dementia. Self‐ or informant reports are most commonly used but can be biased and may not reflect actual functional ability. Alternatives include performance‐based assessments, such as the Sydney Test of Activities of daily living in Memory disorders (STAM). The aim of this study is to develop, and validate, a new computerised diagnostic tool (C‐STAM) to assess functional ability that can be administered remotely to increase accessibility. The C‐STAM will realistically simulate everyday activities to assess functional performance.Method: The C‐STAM is being developed by a multidisciplinary team of psychologists, old age psychiatrists, occupational therapists, and computer scientists. A Delphi study with 31 international experts was conducted to select and refine suitable tasks. An additional step is consultation with consumers (i.e., older people with and without cognitive impairment) and caregivers who have an active role in shaping the C‐STAM. A pilot study with 30 people aged 60+ with normal cognition, MCI, and dementia plus their informants will assess feasibility and user‐experience. After adjustments based on the pilot study, we will conduct a validation study with 180 participants and their informants.Result: The Delphi study resulted in nine C‐STAM tasks, addressing the domains of communication, shopping, dressing, community mobility, handling finances, managing medications, and memory. Feasibility and acceptability of these tasks will be confirmed through pilot testing and the validation study. We will develop an automated scoring and interpretation guide, age‐ and sex‐specific norms, and clinical cut‐offs to differentiate the three diagnostic groups. Automated data exporting and reporting will be useful for clinical referrals and in research and will facilitate interpretation and communication of results across different clinical settings.Conclusion: The C‐STAM will facilitate early diagnosis of dementia and MCI and will enable a better understanding of disease progression by monitoring functional ability in a time‐ and resource‐efficient way. Results will be used to inform service development to better meet the needs of people with dementia for access to appropriate assessments of functional performance. The C‐STAM will be freely available for use by clinicians and in research.